Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5427]
News [12614]
Articles [173]
Editorials [5]
Conferences [246]
elearning [17]
What is the biology behind immunotherapy for MM?
Dr Alexander Lesokhin - Memorial Sloan Kettering Cancer Center, New York, USA
What is the biology behind immunotherapy for MM? ( Dr Alexander Lesokhin - Memorial Sloan Kettering Cancer Center, New York, USA )
3 Mar 2017
Evolving role of MRD negativity in multiple myeloma
Prof Jesús San Miguel - University Hospital, Salamanca, Spain
Evolving role of MRD negativity in multiple myeloma ( Prof Jesús San Miguel - University Hospital, Salamanca, Spain )
3 Mar 2017
Carfilzomib, cyclophosphamide, and dexamethasone in newly diagnosed multiple...
Dr Ralph Boccia - Center for Cancer and Blood Disorders, Bethesda, USA
Carfilzomib, cyclophosphamide, and dexamethasone in newly diagnosed multiple myeloma ( Dr Ralph Boccia - Center for Cancer and Blood Disorders, Bethesda, USA )
3 Mar 2017
Is precision myeloma medicine more hype than reality?
Dr Suzanne Lentzsch - Columbia University, New York, USA
Is precision myeloma medicine more hype than reality? ( Dr Suzanne Lentzsch - Columbia University, New York, USA )
3 Mar 2017
Asia-Pacific approaches to myeloma trials
Prof Chng Wee Joo - National University Health System, Singapore, Singapore
Asia-Pacific approaches to myeloma trials ( Prof Chng Wee Joo - National University Health System, Singapore, Singapore )
3 Mar 2017
Denosumab vs zoledronic acid for bone disease in newly diagnosed multiple...
Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece
Denosumab vs zoledronic acid for bone disease in newly diagnosed multiple myeloma ( Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece )
3 Mar 2017
Bone disease and management of myeloma complications
Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece
Bone disease and management of myeloma complications ( Prof Evangelos Terpos - University of Athens School of Medicine, Athens, Greece )
3 Mar 2017
Monoclonal antibodies in multiple myeloma
Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain
Monoclonal antibodies in multiple myeloma ( Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain )
2 Mar 2017
Promising myeloma agents in phase II trials
Dr Ruben Niesvizky - New York Presbyterian Hospital-Weill Cornell Medical...
Promising myeloma agents in phase II trials ( Dr Ruben Niesvizky - New York Presbyterian Hospital-Weill Cornell Medical Center, New York, USA )
2 Mar 2017
Ongoing transplant phase III trials for myeloma
Dr Amrita Krishnan - City of Hope Cancer Center, Duarte, USA
Ongoing transplant phase III trials for myeloma ( Dr Amrita Krishnan - City of Hope Cancer Center, Duarte, USA )
2 Mar 2017
Post autologous transplant therapies in high risk multiple myeloma: StaMINA...
Dr Amrita Krishnan - City of Hope Cancer Center, Duarte, USA
Post autologous transplant therapies in high risk multiple myeloma: StaMINA trial update ( Dr Amrita Krishnan - City of Hope Cancer Center, Duarte, USA )
2 Mar 2017
Updates from ASPIRE and ENDEAVOR: Multicenter phase III studies of carfilzomib...
Dr David Siegel - John Theurer Cancer Center, Hackensack, USA
Updates from ASPIRE and ENDEAVOR: Multicenter phase III studies of carfilzomib for relapsed/refractory multiple myeloma ( Dr David Siegel - John Theurer Cancer Center, Hackensack, USA )
2 Mar 2017

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation